First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy
23 janv. 2023 07h01 HE
|
Consilium Strategic Communications
First US leukemia patient dosed with Smart Immune’s investigational SMART101 cell therapy Phase I/II trial will assess safety and efficacy of SMART101 in accelerating immune reconstitution to...